BICKAN
OSE Immunotherapeutics
Mark For: BICKAN® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88103678 |
| Registration Number | 6082825 |
| Mark Literal Elements | BICKAN |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-06-23 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Patrick J. Jennings |
| Attorney Docket Number | 22044-461713 |
| Law Office Assigned | N10 |
| Employee Name | KELLY, JOHN M |
Timeline
| 2018-09-04 | Application Filed |
| 2018-12-31 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-12-31 | Status: Live/Pending |
| 2019-01-01 | Transaction Date |
| 2019-02-05 | Published |
| 2019-02-05 | Published for Opposition |
| 2020-06-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-06-23 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-06-23 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  OSE Immunotherapeutics |
| Address | 22 Boulevard Benoni Goullin Nantes FRANCE 44200 |
| Legal Entity Type | Société Anonyme (sa) |
| Legal Entity State | FRANCE |
Documents
 Drawing | JPEG | 2018-09-04 |
 TEAS RF New Application | MULTI | 2018-09-04 |
| XSearch Search Summary | XML | 2018-12-14 |
| Offc Action Outgoing | XML | 2018-12-15 |
| Response to Office Action | MULTI | 2018-12-20 |
| Amendment and Mail Process Complete | MULTI | 2018-12-29 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2018-12-29 |
| Notice of Publication | XML | 2019-01-16 |
| Notification Of Notice of Publication | XML | 2019-01-16 |
| OG Publication Confirmation | APPLICATION/XML | 2019-02-05 |
| Notice of Allowance | APPLICATION/XML | 2019-04-02 |
| Extension of Time to File SOU | XML | 2019-06-25 |
| ITU Extension Approval | APPLICATION/XML | 2019-06-27 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2019-06-27 |
| Change Address or Representation Form | XML | 2020-02-18 |
| Petition to Director Received | XML | 2020-02-18 |
| Amendment to Delete or Correct Basis | APPLICATION/XML,IMAGE/JPEG | 2020-05-20 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-05-20 |
| Prosecution History for Canceling NOA | APPLICATION/XML,IMAGE/JPEG | 2020-05-20 |
| Registration Certificate | 2020-06-23 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
IC 042. US 100 101. G & S: Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies
IC 044. US 100 101. G & S: Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | (Based on 44(e)) (Based on Intent to Use) Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services |
| GS0051 | Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-06-23 | |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2020-05-19 | 66154 |
| PETITION TO DIRECTOR - DISMISSED | 2020-05-13 | 67832 |
| ASSIGNED TO PETITION STAFF | 2020-05-12 | 67832 |
| NOTICE OF ALLOWANCE CANCELLED | 2020-04-02 | 66154 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-02-18 | |
| TEAS PETITION TO DIRECTOR RECEIVED | 2020-02-18 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-02-18 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-02-18 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-02-18 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-02-18 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-27 | |
| TEAS EXTENSION RECEIVED | 2019-06-25 | |
| EXTENSION 1 GRANTED | 2019-06-25 | 98765 |
| EXTENSION 1 FILED | 2019-06-25 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-04-02 | |
| PUBLISHED FOR OPPOSITION | 2019-02-05 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-05 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-16 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-12-28 | 70138 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-12-28 | 70138 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-28 | |
| ASSIGNED TO LIE | 2018-12-27 | 70138 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-12-20 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-15 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-12-15 | 76071 |
| NON-FINAL ACTION E-MAILED | 2018-12-15 | 6325 |
| ASSIGNED TO EXAMINER | 2018-12-14 | 76071 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-11 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 